Skip to main content
. 2011 Oct 31;2012:156068. doi: 10.1155/2012/156068

Table 7.

Dual Therapeutic intervention.

Targets Drug Phase(s) trial Protocol_IDs*
BRAF and MEK for the MAPK pathway Sorafenib and Temsirolimus I, II NCT00349206
PI3K, AKT and mTOR for the AKT/PI3K pathway MK2206 plus AZD6244 I NCT01021748